glp-1 and ulcerative colitis medications are a major focus for scientists right now., Here’s what’s happening: between 2024 and 2025, at least six studies have been published in respected journals Today's the day. 🔬✨ From

Pharmacotherapy for adults with overweight and obesity: A systematic review and network meta-analysis of randomised controlled trials

Key end points included: hospitalisation, heart failure (ICD-10-CM-I50), myocardial infarction (ICD-10-CM-I21), stroke and transient ischaemic attack (ICD-10-CM-I63, G45), development of diabetic microvascular complications (ICD-10-CM-E10.210.4) and all-cause mortality analysed 3 months to 5 years post drug initiation

GLP-1 receptor agonists, which include semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), mimic a gut hormone released after eating

However, these coupons can only be used when paying cash for your prescription

Pathophysiology of Inflammatory Bowel Diseases

Data extraction and synthesis A detailed data extraction table was developed on Microsoft Excel and data on key study characteristics and outcomes were collected